Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where DHR advanced for three days, in 180 of 323 cases, the price rose further within the following month. The odds of a continued upward trend are 56%.
The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on DHR as a result. In 47 of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 53%.
The Aroon Indicator entered an Uptrend today. In 108 of 195 cases where DHR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 55%.
The 10-day RSI Indicator for DHR moved out of overbought territory on September 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 28 similar instances where the indicator moved out of overbought territory. In 13 of the 28 cases, the stock moved lower in the following days. This puts the odds of a move lower at 46%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 38 of 65 cases where DHR's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 58%.
The Moving Average Convergence Divergence Histogram (MACD) for DHR turned negative on November 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 32 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 68%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where DHR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 59%.
DHR broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Valuation Rating of 15 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.141) is normal, around the industry mean (66.911). P/E Ratio (41.654) is within average values for comparable stocks, (2.514). Projected Growth (PEG Ratio) (1.361) is also within normal values, averaging (3.473). Dividend Yield (0.007) settles around the average of (0.002) among similar stocks. P/S Ratio (5.900) is also within normal values, averaging (9.775).
The Tickeron Price Growth Rating for this company is 19 (best 1 - 100 worst), indicating outstanding price growth. DHR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 56 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 77 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DHR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.
The Moving Average Convergence Divergence (MACD) for PRCS turned positive on November 04, 2026. Looking at past instances where PRCS's MACD turned positive, the stock continued to rise in 17 of 18 cases over the following month. The odds of a continued upward trend are 90%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 17 of 21 cases where PRCS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.
The Momentum Indicator moved above the 0 level on November 04, 2026. You may want to consider a long position or call options on PRCS as a result. In 28 of 34 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 82%.
PRCS moved above its 50-day moving average on November 04, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for PRCS crossed bullishly above the 50-day moving average on November 04, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 3 of 3 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Following a +3.54% 3-day Advance, the price is estimated to grow further. Considering data from situations where PRCS advanced for three days, in 118 of 141 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
The Aroon Indicator entered an Uptrend today. In 62 of 80 cases where PRCS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 77%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PRCS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 70%.
PRCS broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
DHR | ||
|---|---|---|
OUTLOOK RATING 1..100 | 28 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 15 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 77 | |
PRICE GROWTH RATING 1..100 | 19 | |
P/E GROWTH RATING 1..100 | 56 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| DHR | PRCS | |
|---|---|---|
| RSI ODDS (%) | 7 days ago 46% | N/A |
| Stochastic ODDS (%) | 2 days ago 58% | 2 days ago 81% |
| Momentum ODDS (%) | 2 days ago 53% | 2 days ago 82% |
| MACD ODDS (%) | 2 days ago 68% | 2 days ago 90% |
| TrendWeek ODDS (%) | 2 days ago 57% | 2 days ago 81% |
| TrendMonth ODDS (%) | 2 days ago 58% | 2 days ago 82% |
| Advances ODDS (%) | 2 days ago 56% | 2 days ago 84% |
| Declines ODDS (%) | 4 days ago 59% | 14 days ago 70% |
| BollingerBands ODDS (%) | 2 days ago 67% | 2 days ago 88% |
| Aroon ODDS (%) | 2 days ago 55% | 2 days ago 77% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
DHR’s FA Score shows that 2 FA rating(s) are green while .
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
DHR’s TA Score shows that 3 TA indicator(s) are bullish.
DHR (@Medical Specialties) experienced а +0.37% price change this weekfor the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was -8.35%. For the same industry, the average monthly price growth was -7.35%, and the average quarterly price growth was +37.37%.
DHR is expected to report earnings on Feb 03, 2027.
Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
A.I.dvisor indicates that over the last year, DHR has been closely correlated with TMO. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if DHR jumps, then TMO could also see price increases.
| Ticker / NAME | Correlation To DHR | 1D Price Change % | ||
|---|---|---|---|---|
| DHR | 100% | +2.09% | ||
| TMO - DHR | 73% Closely correlated | +1.12% | ||
| RGEN - DHR | 68% Closely correlated | -0.04% | ||
| BIO - DHR | 64% Loosely correlated | +1.35% | ||
| A - DHR | 60% Loosely correlated | +0.97% | ||
| BRKR - DHR | 58% Loosely correlated | +12.90% | ||
More | ||||
A.I.dvisor indicates that over the last year, PRCS has been loosely correlated with FERG. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if PRCS jumps, then FERG could also see price increases.
| Ticker / NAME | Correlation To PRCS | 1D Price Change % | ||
|---|---|---|---|---|
| PRCS | 100% | +3.30% | ||
| FERG - PRCS | 52% Loosely correlated | +2.70% | ||
| HD - PRCS | 42% Loosely correlated | +6.53% | ||
| HUBB - PRCS | 42% Loosely correlated | -2.45% | ||
| DHR - PRCS | 39% Loosely correlated | +2.09% | ||
| VMC - PRCS | 39% Loosely correlated | +4.60% | ||
More | ||||